Efficacy and safety of Yangxin Dingji capsule as an adjunctive therapy for atrial fibrillation: a systematic review and meta-analysis of randomized controlled trials
Background Yangxin Dingji Capsule (YXDJ), a modern Chinese patent medicine derived from the classic Zhigancao Decoction, is commonly used as an adjuvant therapy for atrial fibrillation (AF). This study aimed to comprehensively evaluate the efficacy and safety of YXDJ as an adjuvant therapy in AF patients. Materials and...
Jingshuo Hao, Cong Ma, Jiaqi Ren et al.
· Frontiers in Pharmacology · 0 citations